ALLR
Allarity Therapeutics Inc
NASDAQ: ALLR · HEALTHCARE · BIOTECHNOLOGY
$1.35
-2.17% today
Updated 2026-04-30
Market cap
$21.83M
P/E ratio
—
P/S ratio
68.22x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Allarity Therapeutics Inc (ALLR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $9974.00 | $362287.00 | $143277.00 | $1.46M | $1.46M | $120000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $320000.00 |
| Revenue growth (YoY) | — | — | +3532.3% | -60.5% | +918.3% | +0.1% | -91.8% | -100.0% | — | — | — | — | — |
| Cost of revenue | $62941.00 | $55826.00 | — | — | $2.22M | $5.08M | — | $86000.00 | $106000.00 | $120000.00 | $37000.00 | $9000.00 | — |
| Gross profit | $-62941.00 | $-45851.00 | $362287.00 | $143277.00 | $-761495.00 | $-3.62M | $120000.00 | $-86000.00 | $-106000.00 | $-120000.00 | $-37000.00 | $-9000.00 | $320000.00 |
| Gross margin | — | -459.7% | 100.0% | 100.0% | -52.2% | -247.9% | 100.0% | — | — | — | — | — | 100.0% |
| R&D | — | — | — | — | — | — | $6.37M | $4.22M | $14.20M | $6.93M | $7.10M | $6.10M | $6.60M |
| SG&A | — | — | — | — | — | — | $3.87M | $4.10M | $12.36M | $9.96M | $10.03M | $11.44M | $6.32M |
| Operating income | $-81185.00 | $-68661.00 | $-1.40M | $-4.49M | $-3.84M | $-4.98M | $-17.61M | $-8.32M | $-26.56M | $-34.46M | $-17.13M | $-27.24M | $-12.61M |
| Operating margin | — | -688.4% | -385.5% | -3132.1% | -263.4% | -341.2% | -14675.8% | — | — | — | — | — | -3939.1% |
| EBITDA | $0.00 | $-45852.00 | $-1.13M | $-4.21M | $-3.83M | $-4.90M | $-15.61M | $-6.01M | $-25.77M | $-17.30M | $-11.28M | $-24.23M | $-11.05M |
| EBITDA margin | — | -459.7% | -312.3% | -2937.9% | -262.8% | -335.4% | -13011.7% | — | — | — | — | — | -3451.9% |
| EBIT | $-81185.00 | $-68660.00 | $-1.40M | $-4.49M | $-3.84M | $-4.93M | $-15.66M | $-6.10M | $-25.88M | $-17.36M | $-11.32M | $-24.24M | $-11.03M |
| Interest expense | — | — | $39396.00 | $43696.00 | $2417.00 | $233235.00 | $3.31M | $320000.00 | $640000.00 | $223000.00 | $498000.00 | $653000.00 | $185000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-81185.00 | $-68661.00 | $-1.15M | $-3.68M | $-4.90M | $-2.29M | $-14.31M | $-6.60M | $-26.65M | $-16.06M | $-11.90M | $-24.52M | $-11.23M |
| Net income growth (YoY) | — | +15.4% | -1570.5% | -221.1% | -33.0% | +53.2% | -524.4% | +53.9% | -303.6% | +39.7% | +25.9% | -106.0% | +54.2% |
| Profit margin | — | -688.4% | -316.6% | -2570.4% | -335.7% | -157.0% | -11927.5% | — | — | — | — | — | -3509.7% |